Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

GUIDANT PIPELINE INCLUDES CORONARY STENTS, DIGITAL PTCA CATHETERS, IPO SAYS; LILLY DEVICE GROUP EXPECTS TO GROSS $246 MIL. IN INITIAL PUBLIC OFFERING

This article was originally published in The Gray Sheet

  • News

Executive Summary

Product development projects underway at Eli Lilly device company Guidant include a balloon-expandable stent for coronary uses and a line of coronary angioplasty catheters that incorporates digital inflation control, the company says in a prospectus for an initial public offering filed Sept. 13 with the Securities and Exchange Commission.

Table

View full table

Tags:
Latest Headlines

China’s First Non-Profit Rare Disease Foundation Pleas For Therapies

Obesity Gold Rush To Drive Significant Spending Growth Through Decade, IQVIA Says

With Vertex Pain Drug Filed At FDA, Commercial Ramp Is Under Way

Zenas Raises $200m For Bifunctional Antibody In Autoimmune Diseases

See All
UsernamePublicRestriction

Register

MT002817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By